Paper351801
Chloroquine resistance produced in vitro in an African strain of human malaria.
Nguyen-Dinh P and 1 other. Science, 1978. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Chloroquine resistance produced in vitro in an African strain of human malaria. Papers, record 351801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/351801
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chloroquine | Major topic |
| Plasmodium falciparum | Major topic |
| Animals | |
| Drug Resistance | |
| Mutation |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39848983 | YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates. | Sci Rep | 2025 | https://conductscience.org/library/papers/39848983 | PubMed |
| 33915339 | Antiplasmodial activity of the natural product compounds alstonine and himbeline. | Int J Parasitol Drugs Drug Resist | 2021 | https://conductscience.org/library/papers/33915339 | PubMed |
| 31874839 | The resistome and genomic reconnaissance in the age of malaria elimination. | Dis Model Mech | 2019 | https://conductscience.org/library/papers/31874839 | PubMed |
| 30693210 | Drug susceptibility testing methods of antimalarial agents. | Trop Parasitol | 2018 | https://conductscience.org/library/papers/30693210 | PubMed |
| 20022938 | In vitro selection of Plasmodium falciparum drug-resistant parasite lines. | J Antimicrob Chemother | 2010 | https://conductscience.org/library/papers/20022938 | PubMed |
| 8285616 | Development of halofantrine resistance and determination of cross-resistance patterns in Plasmodium falciparum. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8285616 | PubMed |
| 7028302 | The genetics of drug resistance in malaria parasites. | Bull World Health Organ | 1980 | https://conductscience.org/library/papers/7028302 | PubMed |
| 7018728 | Decrease in susceptibility of Plasmodium falciparum to mefloquine in continuous culture. | Bull World Health Organ | 1981 | https://conductscience.org/library/papers/7018728 | PubMed |
| 6809183 | Chemoprophylaxis of malaria in Africa: the spent "magic bullet". | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6809183 | PubMed |
| 6661356 | Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661356 | PubMed |
| 6380785 | Plasmodium falciparum: mefloquine resistance produced in vitro. | Bull World Health Organ | 1984 | https://conductscience.org/library/papers/6380785 | PubMed |
| 3893775 | Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth. | Bull World Health Organ | 1985 | https://conductscience.org/library/papers/3893775 | PubMed |
| 1786619 | In vitro sensitivity of southern African reference isolates of Plasmodium falciparum to chloroquine and pyrimethamine. | Bull World Health Organ | 1991 | https://conductscience.org/library/papers/1786619 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/351801
GET https://conductscience.org/api/papers/v1/351801/authors